143 related articles for article (PubMed ID: 17228455)
1. Report from the 2nd International Workshop on HIV and Hepatitis Co-Infection, January 12-14, 2006, Amsterdam, Netherlands. Tenofovir or adefovir for hepatitis B.
TreatmentUpdate; 2006; 18(2):4. PubMed ID: 17228455
[No Abstract] [Full Text] [Related]
2. The risk of adefovir monotherapy in human immunodeficiency virus (HIV) and hepatitis B virus (HBV) co-infected patients.
Gelinck LB; Claas EC; Kroon FP
J Hepatol; 2005 Aug; 43(2):360-1; author reply 361. PubMed ID: 15970350
[No Abstract] [Full Text] [Related]
3. Tenofovir helps beat hepatitis B.
TreatmentUpdate; 2003 Jan; 15(1):4. PubMed ID: 12630369
[No Abstract] [Full Text] [Related]
4. [Failure to treat hepatitis B virus infection with adefovir due to early selection of rtA181T mutation].
Rodríguez Dominguez M; de la Loma GA; Moreira Vicente V; Mateos Lindemann M
Med Clin (Barc); 2010 Apr; 134(10):468-9. PubMed ID: 19464708
[No Abstract] [Full Text] [Related]
5. Peg-interferon plus nucleotide analogue treatment versus no treatment in patients with chronic hepatitis B with a low viral load: a randomised controlled, open-label trial.
de Niet A; Jansen L; Stelma F; Willemse SB; Kuiken SD; Weijer S; van Nieuwkerk CMJ; Zaaijer HL; Molenkamp R; Takkenberg RB; Koot M; Verheij J; Beuers U; Reesink HW
Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):576-584. PubMed ID: 28522204
[TBL] [Abstract][Full Text] [Related]
6. Successful therapy of hepatitis B with tenofovir in HIV-infected patients failing previous adefovir and lamivudine treatment.
Schildgen O; Schewe CK; Vogel M; Däumer M; Kaiser R; Weitner L; Matz B; Rockstroh JK
AIDS; 2004 Nov; 18(17):2325-7. PubMed ID: 15577546
[TBL] [Abstract][Full Text] [Related]
7. Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B.
Marcellin P; Heathcote EJ; Buti M; Gane E; de Man RA; Krastev Z; Germanidis G; Lee SS; Flisiak R; Kaita K; Manns M; Kotzev I; Tchernev K; Buggisch P; Weilert F; Kurdas OO; Shiffman ML; Trinh H; Washington MK; Sorbel J; Anderson J; Snow-Lampart A; Mondou E; Quinn J; Rousseau F
N Engl J Med; 2008 Dec; 359(23):2442-55. PubMed ID: 19052126
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral therapy and HIV/hepatitis B virus coinfection.
Benhamou Y
Clin Infect Dis; 2004 Mar; 38 Suppl 2():S98-103. PubMed ID: 14986281
[TBL] [Abstract][Full Text] [Related]
9. Influence of HIV infection on response to tenofovir in patients with chronic hepatitis B.
Plaza Z; Aguilera A; Mena A; Vispo E; Sierra-Enguita R; Tomé S; Pedreira J; Rodriguez C; Barreiro P; del Romero J; Soriano V; Poveda E
AIDS; 2013 Sep; 27(14):2219-24. PubMed ID: 23669158
[TBL] [Abstract][Full Text] [Related]
10. Low-dose adefovir for the treatment of chronic hepatitis B in HIV-infected people.
Brust DG
GMHC Treat Issues; 2001; 15(11-12):8-11. PubMed ID: 11819970
[No Abstract] [Full Text] [Related]
11. Efficacy of combined antiviral therapy with lamivudine and tenofovir in a liver transplanted girl with de novo hepatitis B virus infection.
Tufano M; Liccardo D; Riva S; Candusso M; Torre G; Iorio R
Transpl Infect Dis; 2013 Apr; 15(2):E81-4. PubMed ID: 23387823
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of hexadecyloxypropyl-9-R-[2-(Phosphonomethoxy)propyl]- adenine, CMX157, as a potential treatment for human immunodeficiency virus type 1 and hepatitis B virus infections.
Painter GR; Almond MR; Trost LC; Lampert BM; Neyts J; De Clercq E; Korba BE; Aldern KA; Beadle JR; Hostetler KY
Antimicrob Agents Chemother; 2007 Oct; 51(10):3505-9. PubMed ID: 17646420
[TBL] [Abstract][Full Text] [Related]
13. Effect of switching to tenofovir with emtricitabine in patients with chronic hepatitis B failing to respond to an adefovir-containing regimen.
Santos SA; Uriel AJ; Park JS; Lucas J; Carriero D; Jaffe D; Dieterich DT
Eur J Gastroenterol Hepatol; 2006 Dec; 18(12):1247-53. PubMed ID: 17099372
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls.
Levy V; Grant RM
Clin Infect Dis; 2006 Oct; 43(7):904-10. PubMed ID: 16941375
[TBL] [Abstract][Full Text] [Related]
15. Adefovir dipivoxil for chemotherapy-induced activation of hepatitis B virus infection.
Pérez-Roldán F; González-Carro P; Villafáñez-García MC
N Engl J Med; 2005 Jan; 352(3):310-1. PubMed ID: 15659742
[No Abstract] [Full Text] [Related]
16. Tenofovir disoproxil fumarate in patients with HIV and lamivudine-resistant hepatitis B virus.
Benhamou Y; Tubiana R; Thibault V
N Engl J Med; 2003 Jan; 348(2):177-8. PubMed ID: 12519935
[No Abstract] [Full Text] [Related]
17. Reactivation of viral replication after replacement of tenofovir by adefovir.
van Bömmel F; Berg T
Hepatology; 2005 Jul; 42(1):239-40. PubMed ID: 15962310
[No Abstract] [Full Text] [Related]
18. Switching patients with lamivudine resistant chronic hepatitis B virus from tenofovir to adefovir results in less potent HBV-DNA suppression.
Leemans WF; Janssen HL; Niesters HG; de Man RA
J Viral Hepat; 2008 Feb; 15(2):108-14. PubMed ID: 18184193
[TBL] [Abstract][Full Text] [Related]
19. Nonresponse to adefovir: host or virus dependent?
Schildgen O; Helm M; Gerlich W
J Clin Virol; 2006 Dec; 37(4):327-8. PubMed ID: 17011232
[No Abstract] [Full Text] [Related]
20. Recent studies of adefovir dipivoxil for hepatitis B.
Rosenthal P
J Pediatr Gastroenterol Nutr; 2003 Sep; 37(3):323-4. PubMed ID: 12968596
[No Abstract] [Full Text] [Related]
[Next] [New Search]
